electroacupuncture
OtherPatient receive analgetic medicine will get experimental procedure with needle insertion that attach to eletrostimulator
NCT Number: NCT06073496
Gynecological cancer is cancer that starts in the female reproductive organs. Pain in gynecological cancer can be caused by an underlying malignancy or surgical procedure as well as chronic pain associated with malignancy and sequelae of the therapy given. Gynecological cancer patients often experience moderate to severe pain and use higher levels of opioids than patients diagnosed with other cancers. More than two thirds of patients with advanced cancer experience severe pain and up to half of these patients report that their pain is not well controlled. This study aims to analyze the effectiveness of electroacupuncture plus standard therapy on pain intensity (VAS score), changes in analgesic dose, and quality of life (QLQ C-30 EORTC score) in patients with gynecological cancer pain compared to standard therapy alone.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Fatmawati Hospital, Jakarta, DKI Jakarta, Indonesia
This study was conducted using single blinded randomized control clinical trial, design in 58 patients diagnosed with gynecological cancer, aged 18 to 65 years, who experienced cancer pain, with VAS ≥ 4, pain caused by a tumor, before or while undergoing a therapeutic process (radiation therapy, chemotherapy, or post surgery), side effects or due to the toxicity of cancer treatment, willing to take part in this study and sign informed consent who were randomized into 2 groups, namely group I electroacupuncture with standard therapy and group 2 standard therapy, the acupuncture points used were LI4, PC6, ST36, SP6 and LR3, after the acupuncture needle was inserted, the needle was connected to the electrosimulator. The outputs assessed were pain intensity using the VAS, changes in analgesic dose, and quality of life with the EORTC QLQ C-30 questionnaire, which was assessed on the day before starting therapy, the first day, the second day, the third day, the fifth day and the seventh day.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient receive analgetic medicine will get experimental procedure with needle insertion that attach to eletrostimulator
Time frame: Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
Rating scale for measuring pain, where the minimum value is 0 = no pain, and the maximum value is 100 = severe pain. A higher scale means worse outcomes.
Time frame: before treatment and 7 day after treatment
A Quesionaire for measuring quality of Life
Time frame: Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
by assessing drug dose reductions and frequency before and after
Indonesia University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06070363
Acupuncture, Cancer Pain
Jakarta, Dki Jakarta, Indonesia
View Trial DetailsNCT06728709
Gynecologic Cancer, Lung Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05185947
Abdominal Neoplasms, Adenocarcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT05044975
Gynecologic Cancer, Mental Disorders
Tucson, Arizona, United States
View Trial Details